GWAS |
|
- Advanced age-related macular degeneration ( 26691988)
- Age-related macular degeneration ( 20385819 32741009 23577725 23536807 23455636 23326517 22694956 21665990 20861866 15761122 20385826)
- Age-related macular degeneration (choroidal neovascularisation) ( 22705344)
- Age-related macular degeneration (extreme sampling) ( 23577725)
- Age-related macular degeneration (geographic atrophy) ( 22705344)
- Age-related macular degeneration (MTAG) ( 32277175)
- Aspartate aminotransferase levels ( 33547301)
- Chronic central serous retinopathy ( 30073298 30480742)
- Circulating myeloperoxidase levels (serum) ( 23620142)
- Complement C3 and C4 levels ( 23028341)
- Complement C3 levels ( 33941608)
- Complement factor H binding to malondialdehyde ( 32321835)
- Complement factor H levels ( 34260947)
- Complement factor H-related protein 2 levels ( 34260947)
- Complement factor H-related protein 3 levels ( 34260947)
- Complement factor H-related protein 4A levels ( 34260947)
- Complement factor H-related protein 5 levels ( 34260947)
- Disease progression in age-related macular degeneration ( 29346644)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Disease progression to geographic atrophy form in age-related macular degeneration ( 29346644)
- Early age-related macular degeneration ( 32843070)
- Exudative age-related macular degeneration ( 25629512)
- Fuchs's corneal dystrophy ( 28358029)
- Liver enzyme levels (alanine transaminase) ( 33972514)
- Matrix metalloproteinase-8 levels ( 29212897)
- Meningococcal disease ( 20694013)
- Neovascular age-related macular degeneration ( 28703135)
- Nephropathy ( 21399633)
- Post bronchodilator FEV1/FVC ratio in COPD ( 26634245)
- Rheumatic heart disease ( 34106200)
- Serum C3d:C3 ratio (systemic complement activation) ( 29398083)
- Sub-foveal choroidal thickness ( 29844195)
- Systemic lupus erythematosus ( 28714469)
- Waist-to-hip ratio adjusted for BMI ( 34021172)
|